In the week ending August 08th 2025, HFR reported that hedge funds extended strong 1H gains to begin the second half of the year, with leadership accelerating from directional Event Driven and Equity ...

The 2025 Edition of law firm Seward & Kissel's Established Manager Hedge Fund Study analyses investment managers with at least five years of experience and $1bn in regulatory AuM. The study ...

The US accounted for $70 billion of the Americas' investment total - and for nearly 70 percent of all venture capital (VC) investment globally, said a study.

Liquid Alternative UCITS strategies advanced in July, as the HFRX Market Directional Index gained +1.3 percent, while the HFRX Global Hedge Fund Index added +0.6 percent for the month. HFRX strategy ...

New policies proposed by the US administration and regulatory changes are set to have a devasting impact on endowment funds. New analysis and scenario mapping carried out by Ortec Finance reveals that ...

SEC Commissioner Hester Peirce recently delivered a powerful address at the Science of Blockchain Conference titled "Peanut Butter & Watermelon: Financial Privacy in the Digital Age". In it, she ...

Global investment firm Carlyle has closed another U.S. opportunistic real estate fund (CRP X), raising $9 billion, which will target multiple asset classes. The Washington, D.C.-based alternative ...

On August 6, 2025, the U.S. Securities and Exchange Commission (SEC) announced a settled enforcement action against MUFG Securities EMEA plc, a UK-based security-based swap dealer (SBSD) registered ...

The New York-based healthcare investor beat its $1.75 billion goal for OrbiMed Royalty and Credit Opportunities Fund V. The fund, which closed on Friday, follows the $1.71 billion OrbiMed raised for ...

Conditional legal conclusions: Buried in footnotes, the staff repeatedly warns that its legal conclusions only apply if all those factual assumptions are true - meaning any deviation in real-world ...

Global venture capital (VC) investment in generative artificial intelligence (GenAI) surged to $49.2 billion in the first half of 2025, outpacing the total for all of 2024 ($44.2 billion) and more ...

The Palo Alto-based venture firm Frazier Life Sciences has closed a new venture capital fund for startup creation and investing in early-stage biotechnology companies, raising $1.3 billion.